Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sameer Satija

Clinical Cardiac Electrophysiology Margate, FL Medical Doctor

NPI 1235317876 CMS profile 192421

2825 N State Road 7, Suite 303, Margate, FL 33063

Open in the dashboard

General payments

$65,776

1,385 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$350 paid to institutions, not to them · program year 2023

Through program year 2025, Sameer Satija of Margate, FL is reported in the CMS Open Payments database as having received $65,776 across 1,385 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $350 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 81st percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,068 201
2024 General $8,745 212
2023 General $9,204 222
2022 General $8,542 202
2021 General $8,568 271
2020 General $5,995 145
2019 General $17,653 132

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sameer Satija
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Sameer Satija were reported at $7,068. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Sameer Satija Clinical Cardiac Electrophysiology median Middle half National median
2019 $17,653 $2,361 $585–$8,260 $163
2020 $5,995 $993 $247–$4,351 $114
2021 $8,568 $1,185 $326–$4,739 $132
2022 $8,542 $2,073 $554–$6,789 $149
2023 $9,204 $2,568 $759–$8,159 $160
2024 $8,745 $2,557 $703–$7,403 $164
2025 $7,068 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $24,119 561 payments
  2. Medtronic, Inc. $18,188 429 payments
  3. Pfizer Inc. $7,188 31 payments
  4. Boston Scientific Corporation $3,647 120 payments
  5. E.R. Squibb & Sons, L.L.C. $3,381 14 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $2,557 24 payments
  7. Atricure, Inc. $1,407 20 payments
  8. Biosense Webster, Inc. $1,067 40 payments
  9. Janssen Pharmaceuticals, Inc $728 40 payments
  10. Cordis US Corp. $642 5 payments
  11. Other $2,851 101 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $48,509 1,348 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,325 7 payments
  3. Travel and Lodging $4,050 24 payments
  4. Consulting Fee $1,844 4 payments
  5. Education $49 2 payments
Products named General payments · program years 2019–2025
  1. ELIQUIS Cardiovascular;Metabolic Disease $7,158 30 payments
  2. COBALT DR MRI SURESCAN $5,280 86 payments
  3. Confirm Rx Cardiac Arrhythmias and Heart Failure $3,859 58 payments
  4. ELIQUIS Cardiovascular $3,357 13 payments
  5. TYRX $2,575 41 payments
  6. LifeVest $2,557 24 payments
  7. AZURE XT DR MRI SURESCAN $1,894 62 payments
  8. Assurity Pacemaker $1,742 33 payments
  9. Confirm Rx Cardiac Rhythm Management $1,498 28 payments
  10. LINQ II $1,377 57 payments
  11. Other $33,969 955 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

964

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$304,552

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

56.4%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 210 $183,844
Xarelto Rivaroxaban Brand 122 $111,040
Flecainide Acetate Generic 85 $2,940
Metoprolol Succinate Generic 146 $1,531
Sotalol Sotalol Hcl Brand 121 $1,517
Midodrine Hcl Generic 12 $1,358
Sotalol Af Sotalol Hcl Brand 56 $685
Clopidogrel Clopidogrel Bisulfate Brand 35 $491
Amiodarone Hcl Generic 56 $445
Metoprolol Tartrate Generic 67 $269

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$382,684

Medicare's payments for the services billed

Medicare patients

707

Average age 78

Services billed

4,194

310 women, 397 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 72%
Ischemic heart disease 66%
Arthritis 51%
Heart failure 49%
Chronic kidney disease 44%
Diabetes 38%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$77 122 —
Arcalyst
$66 — —
ELIQUIS
$61 210 —
MULTAQ
$55 — —
ONPATTRO
$26 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

1,385 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record